top of page

US FDA Panel Backs Merck's At-Home COVID-19 Pill

A panel of expert advisers to the US Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & Co's antiviral pill to treat COVID-19. If the FDA authorizes the drug, it would be the first at-home treatment for the virus nearly two years into the pandemic. The authorization would likely be limited to patients at high risk of developing severe disease, although the exact population would be defined by the agency. At least this is probably going to be a game changer for us through this pandemic!

6 views0 comments


bottom of page